EU Approval of Tavneos Likely to Add Positive Tailwind to Shares of ChemoCentryx (CCXI) - Stifel
Tweet Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating on ChemoCentryx (NASDAQ: CCXI), following a recently announced EU approval of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
